Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer
Authors:
- Natasha B. LeighlNLNatasha B. Leighl
- Ronald FeldRFRonald Feld
- Frances A. ShepherdFSFrances A. Shepherd
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633Journal of Clinical Oncology, 2004
- A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10Journal of Clinical Oncology, 2004
- Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002The Annals of Thoracic Surgery, 2004
- A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the LungNew England Journal of Medicine, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Cancer burden in the year 2000. The global pictureEuropean Journal of Cancer, 2001
- Revisions in the International System for Staging Lung CancerChest, 1997
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984
- Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent DiseaseThe Annals of Thoracic Surgery, 1984